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Adiposity and serum leptin increase in fatty ( fa/fa) BNZ
neonates without decreased VMH serotonergic activity. Am.
J. Physiol. 274 (Endocrinol. Metab. 37): E1009–E1017, 1998.—
Decreased ventromedial hypothalamic (VMH) serotonergic
activity occurs in genetic and diet-induced animal models of
obesity. We previously found that this activity was lower in
adult and in 12-day-old Zucker fa/fa vs. Fa/Fa pups, the fa/fa
animals being identified by their greater adiposity. In the
present study, we evaluated fa/fa rats (Brown Norway-Zucker
hybrids) at ages 2, 4, 7, and 12 days to test the hypothesis that
lower VMH serotonergic activity occurs before increased
adiposity and/or attenuated energy expenditure. Our results
negate this hypothesis. VMH serotonergic activity showed no
consistent genotype differences even at 12 days of age. In
contrast, by day 7, fa/fa vs. Fa/Fa pups had higher serum
leptin concentrations, greater percent body fat, lower resting
and cold-induced energy expenditure, and lower activity of
brown fat thyroxine 58-deiodinase, an enzyme that converts
thyroxine to triiodothyronine. We conclude that the onset of
increased adiposity induced by the fa gene does not require
decreased VMH serotonergic activity and that the lower
serotonergic activity seen in older fa/fa pups may be second-
ary to metabolic consequences of the disruption of the leptin
regulatory pathway.
genetic obesity; energy expenditure; brown adipose tissue;
uncoupling protein; Brown Norway-Zucker rats; thyroxine
58-deiodinase; ventromedial hypothalamus
HYPOTHALAMIC SEROTONERGIC activity appears to contrib-
ute significantly to central regulation of energy balance
(10, 12, 21). This view is supported by evidence from
studies of rodents and humans, including the following
observations: metabolic rate is increased and food
intake is decreased in humans and rodents after sys-
temically administered fenfluramine [which elevates
brain levels of serotonin (5-HT); see Refs. 19, 26, 31];
similar decreases in food intake occur after peripheral
administration of fluoxetine and sertraline (19, 39),
both of which elevate brain 5-HT, and after microinjec-
tion of 5-HT into the paraventricular nucleus (PVN; see
Ref. 21); microiontophoresis of 5-HT excites thoracic
sympathetic preganglionic neurons (24); injection of
5-HT into the PVN or the ventromedial hypothalamic
nucleus (VMH) results in increased firing rates of
sympathetic nerves to brown adipose tissue (35); and
intracerebral ventricular injection of p-chlorophenylala-
nine (which decreases brain 5-HT levels) reduces brown
fat thermogenic capacity (10). In addition, injection of
8-hydroxy-dipropylamino-tetralin (a 5-HT1A agonist)
into the medial and dorsal raphe, where 5-HT cell
bodies are located, results in increased food intake (12).
Because 5-HT1A receptors in the raphe are inhibitory
autoreceptors (7, 15), their activation would decrease
serotonergic transmission from the raphe. All of these
data, as well as the fact that Zucker rats with genetic or
diet-induced obesity exhibit lower 5-HT turnover/
release in their VMH than do their lean counterparts
(32, 33), are consistent with a role for 5-HT in inhibiting
food intake and stimulating sympathetic activity.
The finding that adult obese Zucker rats have blunted
VMH serotonergic activity raised the question of
whether this attenuation is secondary to the rats’
obesity and/or associated metabolic disturbances (e.g.,
hyperinsulinemia and hyperphagia) or whether it oc-
curs earlier in the development of obesity. We ad-
dressed this issue in a previous study in which we
measured indexes of serotonergic activity in the VMH
of 12-day-old Zucker pups that were presumed to be
genetically obese ( fa/fa) by virtue of their high levels of
body fat (34). In comparison with known genetically
lean (Fa/Fa) pups, the presumptive fa/fa pups were
fatter, had higher serum insulin levels, and had lower
VMH serotonergic activity than did the Fa/Fa pups.
However, there was no linear relationship between
VMH serotonergic activity and serum insulin or car-
cass fat. These data led to the conclusion that the lower
serotonergic activity of the 12-day-old Zucker fa/fa
pups was not likely to be secondary to their hyperinsu-
linemia or to their elevated body fat content (34).
Nonetheless, because these variables were elevated in
the fa/fa pups studied, it was not possible to determine
whether the blunted serotonergic activity occurred
before these elevations or before the attenuated energy
expenditure of Zucker fa/fa pups, which occurs by day 2
of age (2, 25, 29).
The present study was undertaken to examine this
issue, i.e., to test the hypothesis that the lower VMH
serotonergic activity observed in rats homozygous for
the fatty ( fa) mutation occurs before the onset of
increased adiposity, increased serum insulin, and/or
blunted energy expenditure. For this, we utilized 2-, 4-,
7-, and 12-day-old Brown Norway-Zucker (BNZ) hy-
brids, in which we could detect the fa gene by using
molecular probes and thus distinguish homozygous
lean (1/1) and obese ( fa/fa) littermates at any age. We
measured VMH levels of 5-HT and its metabolite,
5-hydroxy-3-indoleacetic acid (5-HIAA), circulating con-
centrations of insulin, and resting and cold-induced
energy expenditure. In addition, we assayed serum leptin
as an indicator of the disrupted leptin-adipose feedback
system and as an additional index of adiposity (1), brown
fat uncoupling protein (UCP)-1 content as an index of
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brown fat sympathetically stimulated thermogenic ca-
pacity, and brown fat thyroxine 58-deiodinase activity,
which converts thyroxine (T4) to triiodothyronine (T3).
The latter acts in conjunction with the sympathetic
neurotransmitter, norepinephrine, to regulate expres-
sion of UCP1.
METHODS
Animal Breeding/Care
Brown Norway lean (1/1) female rats obtained from
Charles River were mated with Zucker obese ( fa/fa) male rats
from the Animal Models Core of the University of California
Davis Clinical Nutrition Research Unit. The resulting F1
pups (1/fa) were crossed to each other to yield F2 pups. These
pups carry the fa and/or wild-type (1) allele on a background
that is ,50% Zucker and 50% Brown Norway. All cages were
provided with rat chow (Purina 5008) and water ad libitum.
At day 1 of age (day 0 being the date of birth), each litter was
culled to 10 pups. The afternoon before the experimental day,
the dam and litter were transferred from the vivarium into
the laboratory where they continued to be housed at 22–25°C
on a 14:10-h light-dark cycle (lights on at 0600; off at 2000).
The exception to this was the 2-day-old pups used in Expt. 1,
which were brought into the laboratory on the morning of the
experiment. Although pups of three genotypes were gener-
ated in these crosses, this paper compares the results from
the homozygous lean (1/1) and obese ( fa/fa) pups.
Genotyping
Pups were genotyped using DNA isolated from spleen via a
method similar to that described by Truett et al. (42). Frozen
spleens were ground with a mortar and pestle and incubated
at 65°C for 2.5–3 h (or until completely digested) in a buffer
containing (final concentration) 20 mg pancreatic RNase/ml,
0.1 mg proteinase K/ml, 10 mM Tris, 0.1 mM EDTA, and 0.5%
SDS, pH 8. DNA was extracted using phenol-chloroform
followed by ethanol precipitation. This DNA, resuspended in
10 mM Tris plus 1 mM EDTA, was used to genotype the pups
either by restriction fragment-linked polymorphism (RFLP)
analysis or by single sequence length repeat (SSR) analysis.
For the RFLP analysis (40), genomic DNA was digested with
Taq I, electrophoresed through a 1% agarose gel, transferred
to nylon membrane (Duralon, Stratagene, LaJolla, CA) by
capillary action with 153 SSC (13 SSC 5 0.15 M NaCl and
0.015 M sodium citrate, pH 7.0), and fixed by ultraviolet
cross-linking (UVP, San Gabriel, CA). These Southern blots
were prehybridized at 60°C for ,60 min in 53 SSPE (13
SSPE 5 0.15 M NaCl, 0.01 M NaH2PO4, and 1 mM EDTA
disodium salt, pH 7.4), 53 Denhardt’s (13 Denhardt’s 5
0.02% polyvinylpyrrolidone, 0.02% Ficoll, and 0.02% BSA),
0.5% SDS, 100 µg/ml salmon sperm DNA, and 10% dextran
sulfate. Approximately 50 ng of the human DNA fragment
VC85 (American Type Culture Collection, Rockville, MD)
were radioactively labeled with [a-32P]ATP (Amersham, Ar-
lington Heights, IL) via random priming, isolated in low-
melting-temperature agarose (9), and used as a probe. Blots
were washed two times with 23 SSC, 0.5% SDS at 65°C for 5
min each wash, one time with 13 SSC, 0.5% SDS at 65°C for
60 min, and finally with 0.53 SSC, 0.5% SDS at 65°C for 60
min. Obese ( fa/fa) animals showed a distinctly different
banding pattern when compared with 1/1 animals (40). SSR
analysis was performed according to the method of Kershaw
et al. (18), which utilizes the polymerase chain reaction (PCR)
with genomic DNA as a template. Primers based on se-
quences from the phosphoglucomutase locus, 1.25 cM from
the fa gene, and the complement component 8 polypeptide
locus, 3.74 cM from the fa gene, were used to amplify
microsatellite polymorphisms that exist between the Zucker
and Brown Norway strains. The resulting PCR products were
run on 6% nondenaturing polyacrylamide gels at 350 V
overnight and stained with ethidium bromide (0.5 µg/ml, 30
min). Pups showing recombination were excluded from the
study.
Body Composition; Serum Insulin, Glucose, and Leptin;
Tissue Protein
Composition of the eviscerated carcasses (minus the head
and interscapular and cervical brown fat depots) was deter-
mined gravimetrically following the method of Bell and Stern
(3). Serum glucose was measured by the glucose oxidase
method using a Beckman Glucose Analyzer (Beckman Instru-
ments, Irvine, CA). Serum leptin (Expt. 1) was analyzed by
radioimmunoassay using mouse anti-leptin sera (Linco, St.
Charles, MO; see Ref. 1). Serum insulin (Expt. 2) was also
measured by radioimmunoassay as previously described (34).
Purified rat insulin served as the reference standard (21.3
U/mg; Novo Biolab, Wilton, CT), porcine insulin antisera was
purchased from ICN Diagnostics (Costa Mesa, CA), and
125I-labeled insulin (1,800–2,100 Ci/nmol) was obtained from
Amersham. Protein was measured using the bicinchoninic
acid (BCA) assay kit (Pierce, Rockford, IL).
Experiment 1
Oxygen consumption. Pups were removed from the dam
between 0700 and 0800, weighed, and placed into individual
Plexiglas metabolic chambers submerged in a water bath for
which the temperature was initially set at thermoneutrality.
In preliminary experiments, we determined thermoneutral-
ity for each age by ascertaining the temperature range at
which there was minimal oxygen consumption (age 2 days:
32–34°C; 4 days: 31–33°C; 7 days: 28–30°C; 12 days: 27–
29°C). Ambient temperature in each of the nine metabolic
chambers was monitored with a YSI (Yellow Springs) ther-
mister. Oxygen consumption was measured in an open system
using an Ametek S3-A oxygen analyzer and a Houston strip-
chart recorder. The S3-A can detect oxygen differences
of 0.01%. In this experiment, the dried airflow rate was 200
ml/min for the 2-, 4-, and 7-day-old pups and 400 ml/min for
the 12-day-old pups; the chamber size was ,200 ml; and the
time for 99% washout of the system was ,4.9 min at 200
ml/min flow and 2.5 min at 400 ml/min flow. Data were
corrected to standard temperature and pressure, and oxygen
volume was calculated on the basis of Eq. 4 in the study by
Hill (13).
Using three separate oxygen analyzer-recorder systems,
we measured up to nine pups per litter simultaneously over a
range of temperatures by use of the following protocol. Pups
were allowed to acclimate to the chamber for at least 30 min
at thermoneutrality. Resting rates were then recorded over
an additional 30–60 min such that, for every pup, we
obtained three to four values, each recording period lasting at
least 5 min. After this, the chamber temperature was lowered
in steps of 1°C every 30 min until oxygen consumption passed
the maximum for each pup. As each pup reached this point, it
was removed from the chamber, its rectal temperature was
measured, and it was decapitated. Because not all pups
reached maximal oxygen consumption at the same tempera-
ture, pups were removed and killed at varying times. Gener-
ally, all nine pups were killed and tissues harvested within
the span of 1 h. Immediately after decapitation, brown
adipose tissue from the interscapular and cervical regions
was removed, frozen in liquid nitrogen, and stored at 270°C
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until preparation for UCP1 and deiodinase analyses; spleen
was removed, similarly frozen, and stored at 270°C until
used for genotyping; trunk blood was collected and centri-
fuged at 16,000 g for 20 min at 4°C, and the resulting serum
was stored at 270°C until measurement of leptin; and the
eviscerated carcass was stored at 220°C until body composi-
tion measurement.
UCP1. UCP1 was measured in brown fat homogenates by
immunoassay using a modification of the method of Lean et al.
(20). Homogenate aliquots (2–12 µg protein/well) were separated
by SDS-PAGE (3% acrylamide stacking gel with an 11% lower
gel). The resulting protein bands were transferred to nitrocellu-
lose membranes, which were then blocked with nonfat dry milk,
and probed with rabbit anti-rat UCP1 sera. UCP1 was detected
using goat anti-rabbit antibody coupled to alkaline phosphatase
(Bio-Rad, Richmond, CA) and quantified via scanning densitom-
etry. Rat UCP, purified by the method of Lin and Klingenberg
(22), served as the standard. The anti-rat UCP1 sera did not
react with liver or muscle homogenates, indicating little, if
any, cross-reactivity with UCP2 or UCP3.
Thyroxine 58-deiodinase activity. Brown fat was thawed
and homogenized in a buffer (9 vol/wt) containing (final
concentration, in mM) 250 sucrose, 1.0 HEPES, 1.0 tetraso-
dium EDTA, and 5.0 dithiothreitol, pH 7.0. A sample was
taken for measurement of protein (via the BCA assay), and
the remaining portion of the homogenate was stored at
270°C until the day of assay when it was thawed, sonicated,
and diluted to 5 µg protein/µl. At least three concentrations of
the homogenate were incubated for 60 min at 37°C in a
shaking water bath with 3 nM T4 containing trace amounts of
125I-labeled T4 (,50,000 counts/min per incubation vial of 100
µl). The 125I-T4, which was labeled at the 58 and 38 positions
(New England Nuclear Labs; specific activity, 4,400 Ci/mmol;
320 µC/ml), was purified of free 125I on a column containing
Sephadex LH-20 (25–100 µm particle size). After the 1-h
incubation, vials were removed from the bath, bovine serum
albumin (50 µl of 8% BSA) was added to bind T4 and T3, and
trichloroacetic acid (350 µl of 10% trichloroacetic acid) was
added to precipitate the protein. The incubation vials were
then centrifuged for 3 min at 16,000 g, the protein pellet was
discarded, and the supernatant was passed over a column of
Dowex 50W-X2 (dry mesh 100–200) to remove any residual T3
and T4. The 125I in the eluant was quantified using a Packard
5360 Auto-Gamma counter, and the amount of 125I present in
control vials (no homogenate) was subtracted from that in
each experimental vial.
Experiment 2
General protocol. A second group of 12-day-old F2 pups was
generated, housed, and brought into the laboratory as de-
scribed above. However, these pups were not cold exposed.
Rather, the pups were separated from their dams at 0600
(immediately after lights on) and placed in individual card-
board boxes containing a layer of Kimwipes. The top of the
box was covered loosely with a Kimwipe to reduce effects of
air currents, and the box was positioned on a surgical heating
pad (37°C) such that a thermal gradient was established and
the pups could move to the thermal region of their choice.
Using this protocol, we have found the air temperature in the
boxes to be between 27 and 29°C and the PO2 and PCO2 to be
similar to those in uncovered boxes. Pups were decapitated
between 0800 and 0830, and their brains were rapidly
removed, frozen on dry ice, and stored at 270°C until
prepared for assay. Blood was collected, and serum was frozen
and stored at 270°C until assayed for insulin. The carcasses
were eviscerated and frozen until analysis of carcass composi-
tion as described above.
Brain dissections and analysis of 5-HT and 5-HIAA. The
VMH was dissected according to the method of Palkovits (27).
Brains were sectioned into 300-µm slices from which tissue
punches were taken bilaterally in the VMH using a blunt
21-gauge needle. The starting points for coordinates were
those from Sherwood and Timiras (37) for 10-day-old rat
pups. These were then compared with our own atlas gener-
ated using 4-, 7-, and 12-day-old BNZ brains that were frozen,
sliced into 80-µm sections, and stained for Nissl substance.
Landmarks were distinguished by vascularity because white
matter was not completely formed at 12 days of age. Anterior-
posterior location was determined by the lateral ventricles,
hippocampus, interpeduncular nucleus, and the pontine nu-
clei; and the location of the VMH was determined by its
relationship to the third and fourth ventricles and its dis-
tance from the ventral border of the brain. Samples were
placed in 210-µl cold mobile phase containing dihydroxyben-
zylamine as an internal standard, sonicated for 5–10 s, and
centrifuged for 30 min at 19,000 g. The supernatant was
stored at 270°C until analysis of 5-HT and its metabolite
5-HIAA. The pellet was stored at 270°C until determination
of protein using the BCA assay method.
5-HT and 5-HIAA were analyzed using HPLC with electro-
chemical detection as described by Routh et al. (33). Peaks
were quantified by area and compared with a regression line
fitted to a series of standards analyzed throughout the day.
Correlation coefficients for the standard lines always exceeded
0.97. The mobile phase consisted of 0.106 M chloroacetic acid
buffer containing 0.45 mM EDTA, 0.40 mM 1-octanesulfonic
acid, and 6.5% methanol, pH 2.9. Standards were solubilized
in 0.131 M acetic acid containing 4.8 mM sodium bisulfate
and 0.67 mM disodium EDTA. Ultrapure water (18 MV 3 cm
resistance) was used for all solutions.
Levels of 5-HT and 5-HIAA are indexes of the activity of the
serotonergic system in the VMH. The amount of 5-HT was
taken to represent the 5-HT pool available under steady-state
conditions (41); the amount of 5-HIAA was considered to be
an index of 5-HT release; and the ratio of 5-HIAA to 5-HT was
taken to be an index of turnover (11).
Statistical Analysis
All data (except for that from selected subsets of fa/fa and
Fa/Fa pups in Expt. 2) were analyzed by multifactorial
ANOVA with main effects of genotype and gender within age
groups. Where significant differences occurred, a one-way
ANOVA with a protected Fisher’s least significant difference
post hoc test was used for specific group comparisons. In Expt.
2, in addition to analyzing the data from all pups as indicated
above, several variables were also analyzed in subsets of the
two genotypes. This analysis was done by the Mann-Whitney
rank-sum test. For all analyses, differences were considered
significant at P # 0.05.
RESULTS
Experiment 1
Body mass, carcass mass, body composition, and
brown fat thermogenic capacity. Although the fa/fa
males were heavier than the fa/fa females at 2 days of
age (7.05 6 0.16 vs. 6.00 6 0.20 g, respectively), this
was not true of the lean pups. Additionally, there were
no significant gender or genotype differences in body
composition at this age (data not shown). Similarly, at 4
days of age, no significant effects of genotype or gender
were observed for body mass, carcass mass, fat-free dry
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mass (g or percent), or body fat (g or percent; Table 1).
However, at day 7, percent carcass fat of the fa/fa pups
was significantly greater than that of the 1/1 pups
(P 5 0.005; Table 1) despite the absence of significant
differences in body mass (P 5 0.48), carcass mass (P 5
0.73), or absolute amount of fat (g; P 5 0.06). By day 12,
both absolute and relative (percent) amounts of carcass
fat were greater in the fa/fa vs. 1/1 pups, with no
gender differences in fat content (Table 1). Thus, be-
tween ages 4 and 7 days, increased carcass adiposity in
the fa/fa genotype became detectable.
In contrast, there were few significant genotype or
gender differences in brown fat mass, protein, or UCP1
content at the four ages studied. The exceptions were at
day 4 when brown fat mass (g) and total protein (mg)
were higher in the fa/fa vs. 1/1 pups. At no age did we
observe significant genotype differences in UCP1 (ei-
ther total or body mass corrected) despite increases
with age (data for 4, 7, and 12 days shown in Table 2).
Thyroxine 58-deiodinase activity. Genotype differ-
ences in the thyroxine 58-deiodinase activity of brown
fat removed from the cold-exposed pups were present at
7 and 12 days but not at 2 and 4 days (Table 2; 2-day-old
data not shown). At both of the older ages, activity
(expressed in terms of mg protein, total, or total
corrected for body mass) was significantly lower in the
fa/fa vs. 1/1 animals. For example, at 7 days of age, the
body mass-adjusted activity in males was 1.25-fold
higher in 1/1 vs. fa/fa rats, and in the females, it was
2.5-fold higher. At 12 days of age, these differences had
risen to 2.6 and 5.8, respectively.
Resting (minimal) and cold-exposed (maximal) rates
of oxygen consumption. Minimal values of oxygen con-
sumption (Table 3) showed no genotype or gender
differences at days 2 (data not shown) or 4 of age. By
day 7, the fa/fa pups exhibited lower minimal rates of
oxygen consumption than did the 1/1 pups, this effect
being more pronounced in females than in males (Table
3). The genotype difference was present in metabolic
rates adjusted for body mass (ml oxygen/h 3 g body
mass0.67) as well as in unadjusted rates (i.e., ml oxygen/
h). This genotype difference was also present at 12 days
of age (Table 3).
Cold exposure increased the oxygen consumption of
all pups (Table 3), with genotype differences in the
response to cold occurring in 7- and 12-day-old pups but
not in the 2- and 4-day-old animals. In general, the lean
7- and 12-day-old pups had greater maximal rates of
oxygen consumption (body mass adjusted; Table 3) and
greater cold-induced rates of oxygen consumption than
did the fa/fa pups. Associated with this blunted thermo-
genic response of the fa/fa pups was the greater degree
of hypothermia observed at the cessation of the cold
exposure (Table 3). For example, at 7 days of age, the
colonic temperatures of female 1/1 pups averaged
23.9 6 0.6°C when pups were removed from the cham-
ber, whereas those of their fa/fa littermates averaged
21.2 6 1.1°C. Similar patterns were observed in the
12-day-old females as well as in the males at both ages.
Because the fa/fa pups generally reached their maxi-
mal oxygen consumption sooner than did the 1/1 pups,
they tended to spend less time in the cold. Thus the
Table 1. Body mass, adiposity, and leptin concentrations in neonatal BNZ pups
Body Mass, g Carcass Mass, g White Fat Mass, g White Fat, %carcass mass Leptin, ng/ml
4 Day old
FL 8.2060.36 (11) 4.0060.21 (11) 0.2160.03 (11) 4.9060.49 (11) 1.4360.55 (8)
FO 8.5260.32 (11) 4.1760.17 (11) 0.2460.04 (11) 5.6460.70 (11) 5.1462.04 (10)
ML 8.6560.33 (14) 4.2860.20 (14) 0.2260.03 (14) 4.9060.40 (14) 0.5660.04 (5)
MO 8.5960.35 (16) 4.2960.20 (16) 0.2460.03 (15) 5.5360.68 (15) 2.0460.40 (12)
Gend 0.457 0.329 0.899 0.927 0.138
Geno 0.711 0.679 0.360 0.257 0.055
G3G 0.600 0.693 0.809 0.919 0.397
7 Day old
FL 12.3260.39 (19) 6.2360.23 (19) 0.4660.04 (18) 7.2060.44b (18) 1.7560.50 (9)
FO 12.2360.67 (11) 6.2960.41 (11) 0.5760.07 (11) 8.9060.59a (11) 2.8360.60 (9)
ML 13.3160.57 (12) 6.7660.31 (12) 0.4460.05 (11) 6.2560.60b (11) 1.2360.23 (10)
MO 12.5160.82 (14) 6.4560.47 (14) 0.5460.06 (12) 7.7660.54a,b (12) 2.6360.65 (10)
Gend 0.309 0.344 0.603 0.060 0.490
Geno 0.477 0.726 0.059 0.005 0.023
G3G 0.565 0.611 0.887 0.863 0.762
12 Day old
FL 20.3460.71b (11) 10.8460.48 (11) 0.7460.14b (10) 6.6561.02b (10) 1.4560.36b,c (6)
FO 21.0760.83a,b (10) 12.0160.67 (10) 1.2460.16a (10) 10.0860.97a (10) 2.4560.58a,b (5)
ML 21.6560.38a,b (17) 11.7560.24 (17) 0.7260.07b (16) 6.0060.57b (16) 0.9110.07c (17)
MO 22.8060.58a (23) 12.4160.38 (23) 1.2960.10a (22) 10.0660.57a (22) 2.8560.29a (21)
Gend 0.023 0.147 0.923 0.667 0.851
Geno 0.155 0.044 F0.001 F0.001 F0.001
G3G 0.753 0.567 0.754 0.681 0.192
Values are means 6 SE; no. of animals in parentheses. BNZ, Brown Norway-Zucker; F, female; M, male; L, lean (1/1); O, obese ( fa/fa). All
variables, except body mass, were measured in cold-exposed pups. For each age and variable, means with no superscripts or sharing a common
superscript do not differ significantly. In the two-way ANOVAs: Gend, gender; Geno, genotype; G 3 G, gender 3 genotype. Significant P values
are in bold type.
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Table 2. Brown fat mass, protein, thyroxine 58-deiodinase activity, and UCP in neonatal BNZ pups
BAT Mass,
mg
BAT Protein,
mg
Thyroxine 58-Deiodinase Activity UCP
fmol/(mg protein3h) fmol/h fmol/(g BM0.67 3h) µg µg/g BM0.67
4 Day old
FL 9266 (11) 12.960.6 (11) 56.3612.8 (10) 696657 (10) 178641 (10) 9596129 (11) 236631 (11)
FO 123612 (11) 17.161.8 (11) 39.964.0 (9) 6346100 (9) 151620 (9) 1,2706212 (11) 301646 (11)
ML 9968 (14) 13.460.9 (14) 51.6610.3 (12) 7166155 (12) 161632 (12) 1,1626190 (13) 272640 (13)
MO 10566 (16) 15.361.0 (16) 55.4613.1 (12) 8916228 (12) 206652 (12) 9676108 (16) 235628 (16)
Gend 0.660 0.588 0.634 0.439 0.633 0.759 0.694
Geno 0.829 0.011 0.581 0.751 0.817 0.721 0.702
G3G 0.064 0.314 0.375 0.351 0.383 0.124 0.166
7 Day old
FL 12765 (19) 19.060.8 (19) 51.264.6a (10) 917694a (10) 176616a (10) 1,9106190 (19) 366640 (19)
FO 11766 (11) 17.661.1 (11) 14.766.8b (8) 234693c (8) 46618b (8) 2,3006320 (11) 435656 (11)
ML 11867 (12) 19.761.4 (12) 32.667.8a (10) 7046191a,b (10) 120630a,b (10) 2,1406250 (12) 384644 (12)
MO 13267 (14) 21.161.2 (14) 19.166.7b (9) 4096145b,c (9) 83632b (9) 2,5706350 (14) 466654 (14)
Gend 0.66 0.055 0.333 0.896 0.845 0.383 0.623
Geno 0.829 0.978 0.007 0.008 0.024 0.148 0.130
G3G 0.064 0.206 0.331 0.436 0.165 0.946 0.887
12 Day old
FL 14468 (11) 25.462.7 (11) 35.6612.7 (8) 9966371 (8) 141654 (8) 3,8156429 (10) 513659 (10)
FO 14968 (10) 24.261.7 (10) 8.163.1 (6) 180666 (6) 2469 (6) 3,3446472 (9) 444663 (9)
ML 13666 (17) 23.461.2 (17) 32.2615.1 (8) 7356376 (8) 93647 (8) 3,6266393 (16) 467649 (16)
MO 15967 (23) 25.361.0 (23) 11.763.9 (10) 284695 (10) 35611 (10) 3,8626321 (23) 476638 (23)
Gend 0.891 0.773 0.991 0.778 0.624 0.699 0.900
Geno 0.079 0.820 0.028 0.030 0.028 0.782 0.568
G3G 0.214 0.335 0.733 0.514 0.439 0.407 0.460
Values are means 6 SE; no. of animals in parentheses. BM, body mass; BAT, brown adipose tissue; UCP, uncoupling protein. All variables
were measured in cold-exposed pups. For each age and variable, means with no superscripts or sharing a common superscript do not differ
significantly. In the two-way ANOVAs, significant P values are in bold.
Table 3. Oxygen consumption [resting (minimal) and cold exposed (maximal)] and colonic temperature
in neonatal BNZ pups
V˙O2, ml·h21 ·g BM20.67 V˙O2, ml/h
Colonic
Temperature, °CResting Cold exposed Resting Cold exposed
4 Day old
FL 3.1860.09 (10) 7.3260.27 (10) 13.1060.50 (10) 30.3361.81 (10) 26.660.5 (11)
FO 3.0660.15 (10) 6.7860.40 (10) 12.7360.74 (10) 28.3162.03 (10) 26.360.2 (12)
ML 3.4660.21 (13) 8.1260.46 (13) 14.5960.90 (13) 34.7062.57 (13) 27.460.5 (14)
MO 3.3960.24 (15) 7.8060.79 (15) 14.4661.17 (15) 34.3263.77 (15) 26.360.3 (16)
Gend 0.146 0.099 0.105 0.093 0.334
Geno 0.649 0.581 0.795 0.693 0.072
G3G 0.893 0.735 0.903 0.787 0.872
7 Day old
FL 3.6660.22a (15) 9.3060.56a (15) 19.7561.20a (15) 49.8761.72a (15) 23.960.6a (19)
FO 2.4860.25c (10) 5.0360.71b (10) 13.2561.31b (10) 26.7663.40b (10) 21.261.1b (11)
ML 3.4060.29a,b (12) 8.3760.96a (12) 19.2261.80a (12) 47.5566.16a (12) 23.760.6a (12)
MO 2.8360.19b,c (11) 4.8160.46b (11) 15.9361.21a,b (11) 27.3363.04b (11) 20.460.7b (13)
Gend 0.844 0.423 0.454 0.832 0.494
Geno F0.001 F0.001 0.001 F0.001 F0.001
G3G 0.213 0.624 0.266 0.726 0.681
12 Day old
FL 3.9360.18 (11) 10.3260.39a (11) 29.2561.58 (11) 76.8263.52 (11) 24.761.5a (11)
FO 3.3560.16 (10) 8.8260.99a,b (10) 25.4761.32 (10) 67.7567.95 (10) 19.761.3b (10)
ML 3.8360.14 (17) 9.8760.45a (17) 29.8061.26 (17) 77.0764.14 (17) 22.161.1a,b (17)
MO 3.6160.15 (23) 7.9960.47b (23) 29.1661.47 (23) 64.6064.28 (23) 20.860.6b (23)
Gend 0.625 0.283 0.187 0.781 0.505
Geno 0.022 0.006 0.169 0.040 0.006
G3G 0.295 0.743 0.328 0.744 0.100
Values are means 6 SE; no. of animals in parentheses. For each age and variable, means with no superscripts or sharing a common
superscript do not differ significantly. In the 2-way ANOVAs, significant P values are in bold.
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genotype differences in colonic temperature that we
noted are probably an underestimate.
Serum leptin concentrations. Serum leptin concentra-
tions (ng/ml) were significantly higher in fa/fa than in
1/1 pups at 7 and 12 days of age (Table 1). Although
leptin levels were also higher in the fa/fa pups at 4 days
of age, the variability in the values precluded reaching
significance (P 5 0.055). There were no significant
gender differences in serum leptin concentrations at
any age. When leptin concentration was expressed in
terms of relative adiposity (ng/ml per %carcass fat), no
genotype or gender differences were observed at any of
the ages studied (data not shown), suggesting that the
amount of carcass fat was a significant factor determin-
ing the leptin concentration in these pups. Linear
regression analysis ascribes ,25% of the variation in
the leptin levels of the pups to percent body fat (Fig. 1).
Experiment 2
Body composition, serum insulin levels, and VMH
concentrations of 5-HT and 5-HIAA. As was the case
with the animals in Expt. 1, the 12-day-old fa/fa pups
were significantly fatter than were the 1/1 pups, both
in absolute (g) and relative (%) terms. This was accom-
panied by larger carcass mass in the fa/fa pups (Table
4). Neither gender or genotype differences were found
in the VMH concentrations of 5-HT, the concentrations
of 5-HIAA, or the ratio of 5-HIAA to 5-HT, indicating no
blunting of VMH 5-HT release. There was no linear
relationship between the indexes of serotonergic activ-
ity and percent body fat (r2 5 0.04; data not shown).
Insulin values were quite variable, so much so that
means 42–158% higher in the fa/fa vs. 1/1 pups did
not differ significantly (Table 4).
To facilitate comparison of the data from the BNZ
pups with those previously obtained on Zucker pups
(34), we also analyzed values of 5-HT, 5-HIAA, the ratio
of 5-HIAA to 5-HT, and insulin from subsets of each
BNZ genotype, namely, fa/fa pups with carcass fat of
11.0–14.6% (n 5 12) and Fa/Fa pups with carcass fat of
7% or below (n 5 8). Data from the 12-day-old males
and females were combined. For these two subsets of
pups, there were no significant genotype differences in
values of 5-HT (fm/µg protein: fa/fa 5 30.8 6 2.0; 1/1 5
29.2 6 3.1), 5-HIAA (fm/µg protein: fa/fa 5 29.2 6 1.5;
1/1 5 26.9 6 2.4), or the ratio of 5-HIAA to 5-HT
(fa/fa 5 0.972 6 0.071; 1/1 5 0.944 6 0.063). However,
insulin values of the selected fa/fa pups (36.6 6 9.8
µU/ml) were significantly higher (P 5 0.015) than those
of the selected 1/1 pups (10.6 6 3.3 µU/ml).
DISCUSSION
The major finding in this study is the observation
that genetically obese ( fa/fa) BNZ pups exhibited
increased serum leptin levels, increased adiposity, and
decreased energy expenditure before any detectable
Fig. 1. Scatter diagram of serum leptin levels plotted against percent
carcass fat for 4-, 7-, and 12-day-old 1/1 (s) and fa/fa (j) Brown
Norway-Zucker pups. With the use of linear regression analysis, the
best-fit line is described by y 5 0.259x 1 0.156; r2 5 0.254, F 5 38.17,
P , 0.001. Rats are from Expt. 1.
Table 4. Ventromedial hypothalamic serotonergic activity and body composition of 12-day-old BNZ pups
Body Mass,
g
Carcass Mass,
g
BAT Mass,
mg
Carcass Fat
Ventromedial Hypothalamus
g %
Insulin,
µU/ml
5-HIAA,
fm/µg protein
5-HT,
fm/µg protein 5-HIAA/5-HT
FL 20.3160.65 10.7560.31 143611c 0.7460.08b 6.8560.56b 21.268.1 28.1562.77 33.5463.77 0.8760.08
(6) (6) (6) (6) (6) (6) (6) (6) (6)
FO 22.3860.38 11.9760.16 18767a 1.2360.09a 10.1760.64a 30.266.2 28.9763.58 29.3262.29 1.0360.08
(9) (9) (9) (9) (9) (9) (9) (9) (9)
ML 20.3860.83 10.8660.52 144611b,c 0.6760.13b 5.9660.91b 8.162.1 26.0762.27 26.5462.00 0.9860.04
(5) (5) (5) (5) (5) (5) (5) (5) (5)
MO 21.4060.53 11.4760.37 16765b 1.1760.13a 9.6760.73a 24.062.2 29.2161.38 28.9061.52 1.0260.03
(14) (14) (14) (11) (11) (11) (12) (12) (12)
Gend 0.438 0.624 0.236 0.587 0.375 0.146 0.622 0.14 0.417
Geno 0.018 0.029 F0.001 F0.001 F0.001 0.156 0.294 0.707 0.121
G3G 0.375 0.448 0.193 0.944 0.808 0.799 0.535 0.188 0.326
Values are means 6 SE; no. of animals in parentheses. 5-HIAA, 5-hydroxy-3-indoleacetic acid; 5-HT, serotonin. All variables were measured
in non-cold-exposed pups. For each age and variable, means with no superscripts or sharing a common superscript do not differ significantly. In
the two-way ANOVA, significant P values are in bold.
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decrease in VMH serotonergic activity. Our previous
analysis of 12-day-old Zucker pups indicated that VMH
serotonergic activity (as indexed by 5-HIAA levels) was
in fact lower in the obese ( fa/fa) vs. homozygous lean
(Fa/Fa) pups (45), but it was not possible to determine
whether this change occurred before the onset of in-
creased fat accretion. To address this, the present study
was designed using BNZ fa/fa and 1/1 littermates
that could be distinguished at any age. Our data
demonstrate that the fa/fa pups increased their adipos-
ity before any measurable decrement in VMH seroton-
ergic activity. A significantly greater percent body fat
was detectable in 7-day-old fa/fa vs. 1/1 pups, indicat-
ing that increased accretion of triacylglycerol in the
adipocytes begins before day 7. In contrast, no signifi-
cant genotype differences in any of the measured
indexes of VMH serotonergic activity were observed at
day 12, even when the ‘‘fattest’’ fa/fa pups were com-
pared with the ‘‘leanest’’ 1/1 pups. Thus, although
decreased VMH serotonergic activity may occur in
older fa/fa pups and may contribute to the degree of
obesity, data from the present study indicate that it is
not essential for the obesity to be manifested.
Similarly, decreased VMH serotonergic activity does
not appear to be necessary for the manifestation of
blunted resting or cold-induced energy expenditure,
both of which were detectable in the BNZ fa/fa pups by
day 7. One potential contributor to the attenuated
resting oxygen consumption is lower availability/
effectiveness of thyroid hormone, a major regulator of
basal metabolism and a hormone that is lower in adult
Zucker fa/fa vs. lean rats (8). Although this has not
been measured in neonatal fa/fa pups, the decreased
activity of thyroxine 58-deiodinase that we observed in
brown fat from these animals is consistent with lower
levels of circulating T3. That is, this deiodinase converts
T4 to T3, the active form of thyroid hormone, and
available evidence suggests that a significant portion of
the T3 generated in brown fat may be released into the
circulation during acute (and prolonged) cold exposure
(38). Another potential contributor to the lower mini-
mal oxygen consumption of the fa/fa pups is diminished
thermic effects of feeding. Although the minimal oxy-
gen consumption was measured at rest and at ther-
moneutrality, the pups were not postabsorptive. Thus
we cannot rule out the possibility of blunted diet-
induced thermogenesis (i.e., sympathetically mediated
increase in oxygen consumption after feeding) or blunted
obligatory metabolism (that associated with nutrient
processing) in these pups as can occur in adult fa/fa rats
(e.g., Refs. 23 and 30).
The attenuated energy expenditure of the fa/fa pups
that occurred during cold exposure (maximal oxygen
consumption) is most likely due to blunted thermogen-
esis in brown adipose tissue, the major site of cold-
induced heat production at this age (6). Activation of
this heat production occurs in response to sympathetic
stimulation of the adipocytes and is mediated by norepi-
nephrine interacting primarily with b-adrenergic recep-
tors in the brown adipocyte plasma membrane. This is
followed by activation of adenylyl cyclase, generation of
cAMP, activation of protein kinase A, phosphorylation
(and activation) of hormone-sensitive lipase, and hydro-
lysis of triacylglycerol. The resulting fatty acids bind to
UCP1 in the mitochondrial membrane and there fol-
lows an increase in proton translocation back into the
mitochondrial matrix. This dissipation of the proton
gradient across the inner mitochondrial membrane
results in uncoupling of oxidative phosphorylation from
the electron transport system and greatly elevated
rates of substrate (fatty acid) oxidation. Heat is re-
leased as a by-product of the substrate oxidation (cf.
Ref. 14).
The blunted cold-induced thermogenesis could in-
volve several mechanisms. Among these is decreased
thermogenic capacity of the tissue resulting from de-
creased UCP1 content. That this is not the case is
demonstrated by the fact that both the concentration
and the total amount of UCP1 were not significantly
lower in the obese vs. lean genotype at any of the four
ages examined. This does not, however, preclude the
possibility of some other factor in the thermogenic
pathway being limiting. Another potential explanation
is that cold exposure elicits more robust signaling to
and/or more effective signal transduction in brown
adipocytes in the lean vs. obese pups. Consistent with
these latter possibilities is the fact that the thyroxine
58-deiodinase activity in brown fat from cold-exposed
pups, an activity that is also stimulated by norepineph-
rine (17), was significantly greater in lean than in obese
pups by day 7 of age. We are currently measuring
urinary norepinephrine to evaluate the effects of cold
exposure on the sympathetic activity of BNZ pups.
The fact that genotype differences in energy expendi-
ture were not detectable at days 2 or 4 in the BNZ pups
but were in Zucker pups (25, 29) most likely reflects the
influence of the Brown Norway background on the
temporal expression of the fatty phenotype. That is,
although the fatty phenotype appears to be comparable
in 9- to 10-wk-old BNZ and Zucker fa/fa rats (4),
attenuation of energy expenditure was delayed in the
fa/fa pups. A similar pattern was observed in VMH
serotonergic activity and serum insulin levels. In both
cases, statistically significant genotype differences were
present in 12-day-old Zucker rats (lower serotonergic
activity and higher circulating insulin in the fa/fa pups)
but not in 12-day-old BNZ pups.
One potential confounding factor in evaluating the
strain differences in insulin and serotonergic activity is
the methodology used to categorize the 12-day-old fa/fa
pups in the two studies. In the Zucker study (34), we
selected the fattest as presumptive fa/fa pups because
molecular methods were not yet available for genotyp-
ing. These presumptive Zucker fa/fa pups had relative
carcass fat values that ranged from 11.5 to 14% (34). In
contrast, the carcass fat of the 12-day-old BNZ fa/fa
pups in the present study ranged from 6.1 to 14.6%.
To eliminate this methodological difference, we ana-
lyzed a subset of the 12-day-old BNZ pups, applying
selection criteria similar to those used for the Zucker
pups. That is, we compared BNZ fa/fa pups with
carcass fat above 11.0% with 1/1 pups with carcass fat
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of 7% and below. The fact that there were still no
genotype differences in any of the measured indexes of
serotonergic activity supports the conclusion that Brown
Norway genes can modulate the time course of the
expression of early events associated with the fatty
phenotype. On the other hand, serum insulin values
were significantly higher in the selected BNZ fa/fa vs.
1/1 pups, suggesting minimal, if any, effects of the
Brown Norway background on the expression of this
variable in the fa/fa pups.
The higher levels of serum leptin observed in the
fa/fa pups are consistent with the nature of the fatty
mutation. This mutation involves substitution of the
amino acid proline for glutamine at residue 269 in the
leptin receptor (16, 28), which renders the receptor
dysfunctional (36, 43), disrupts the leptin-adiposity
feedback pathway that is hypothesized to play a major
role in regulating energy balance (e.g., see Ref. 5), and
initiates the sequence of events culminating in the
metabolic changes associated with the development of
obesity.
In summary, evaluation of several metabolic charac-
teristics of F2 BNZ neonates suggests the following
chronology for the obesity-related variables we mea-
sured in this study. Among the first of the measured
metabolic variables to show genotype differences in the
pups were circulating levels of leptin, which tended to
be higher in the fa/fa vs. 1/1 pups at day 4 of age (P 5
0.055). By day 7, this difference was statistically signifi-
cant as were genotype differences in resting and cold-
induced oxygen consumption, percent body fat, and
brown fat thyroxine 58-deiodinase activity. Thus, be-
tween days 4 and 7, the fa/fa pups in this study began to
exhibit blunted energy expenditure, increased fat depo-
sition, and most likely attenuated sympathetic activity.
Although hyperinsulinemia was not a consistent char-
acteristic of the fa/fa pups even at day 12, the fattest
fa/fa pups (those above 11% carcass fat) did have higher
insulin values than did the leanest 1/1 pups (carcass
fat of 7% and below).
The absence of genotype differences in steady-state
levels of VMH 5-HT, 5-HIAA, and the ratio of 5-HIAA to
5-HT at 12 days of age (even in the fattest pups)
indicates that the fa gene-induced early metabolic
changes leading to the increased accretion of fat do not
require altered VMH serotonergic activity. It also im-
plies that the altered serotonergic activity seen in older
fa/fa pups is most likely a secondary, rather than a
primary, effect of the disruption of the leptin regulatory
pathway.
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